During the past decade, Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" in a lesser frequency.

Most popular intervention types in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" are "Drug" (18 trials), "Other" (2 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (7 trials), "Capecitabine" (4 trials), "Placebo" (4 trials), "Bevacizumab" (3 trials) and "Tiragolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet" are 17 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".